- Home
- GMGI vs GOSS Comparison
GMGI vs GOSS Comparison
Compare GMGI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- GOSS
- Stock Information
- Founded
- GMGI 2008
- GOSS 2015
- Country
- GMGI United States
- GOSS United States
- Employees
- GMGI N/A
- GOSS N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- GOSS Health Care
- Exchange
- GMGI Nasdaq
- GOSS Nasdaq
- Market Cap
- GMGI 263.6M
- GOSS 212.9M
- IPO Year
- GMGI N/A
- GOSS 2019
- Fundamental
- Price
- GMGI $2.09
- GOSS $0.81
- Analyst Decision
- GMGI
- GOSS Strong Buy
- Analyst Count
- GMGI 0
- GOSS 5
- Target Price
- GMGI N/A
- GOSS $9.20
- AVG Volume (30 Days)
- GMGI 159.3K
- GOSS 2.3M
- Earning Date
- GMGI 01-15-2025
- GOSS 11-07-2024
- Dividend Yield
- GMGI N/A
- GOSS N/A
- EPS Growth
- GMGI N/A
- GOSS N/A
- EPS
- GMGI 0.40
- GOSS N/A
- Revenue
- GMGI $87,563,172.00
- GOSS $105,322,000.00
- Revenue This Year
- GMGI $17.07
- GOSS N/A
- Revenue Next Year
- GMGI N/A
- GOSS N/A
- P/E Ratio
- GMGI $4.80
- GOSS N/A
- Revenue Growth
- GMGI 45.05
- GOSS N/A
- 52 Week Low
- GMGI $1.89
- GOSS $0.50
- 52 Week High
- GMGI $6.27
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- GMGI 39.43
- GOSS 49.87
- Support Level
- GMGI $1.89
- GOSS $0.76
- Resistance Level
- GMGI $2.05
- GOSS $0.88
- Average True Range (ATR)
- GMGI 0.12
- GOSS 0.08
- MACD
- GMGI -0.02
- GOSS 0.01
- Stochastic Oscillator
- GMGI 26.97
- GOSS 30.48
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. The company operates in two reportable segments; B2B and B2C. The B2C segment earns majority revenue. The company operates in UK, Asia Pacific and Latin America. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, R Kings Competitions and GM-AG.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.